氰基丙烯酸酯闭合功能不全大隐静脉后超敏反应的回顾性研究
该回顾性研究纳入2017年1月至2018年12月在Siriraj医院接受氰基丙烯酸酯闭合术的101例患者共126条功能不全大隐静脉。结果显示15.8%患者和15.0%肢体发生超敏反应,症状均为轻度,多在术后1周出现,经非甾体抗炎药和抗组胺药治疗1周内缓解。危险因素包括筋膜上静脉距皮肤深度<1 cm及静脉直径≥8 mm。
要点
- 氰基丙烯酸酯闭合术后超敏反应发生率患者水平15.8%,肢体水平15.0%。
- 超敏反应症状均为轻度,术后1周出现,经NSAIDs和抗组胺药治疗1周内缓解。
- 危险因素为筋膜上静脉距皮肤<1 cm及静脉直径≥8 mm,应避免或谨慎操作。
核心结论
- 氰基丙烯酸酯闭合功能不全大隐静脉后超敏反应发生率为患者15.8%、肢体15.0%,均为轻度且可自限。
- 筋膜上静脉距皮肤<1 cm和静脉直径≥8 mm是超敏反应的危险因素。
研究设计与样本
- 回顾性研究,纳入2017年1月至2018年12月泰国Siriraj医院接受氰基丙烯酸酯闭合术的101例患者共126条功能不全大隐静脉。
- 纳入静脉包括大隐静脉106条(84.1%)、前副大隐静脉7条(5.6%)、小隐静脉13条(10.3%)。
主要发现
- 超敏反应发生于16/101例患者(15.8%)、19/126条肢体(15.0%)和19/126条治疗静脉(15.0%)。
- 超敏反应相关红斑、瘙痒、肿胀和疼痛分别发生于100.0%、95.0%、68.4%和52.6%的超敏反应患者。
- 超敏反应发生于氰基丙烯酸酯闭合术后1周,所有症状均为轻度,经非甾体抗炎药和抗组胺药治疗1周内缓解。
关键数值与推荐
- 超敏反应危险因素:筋膜上大隐静脉距皮肤深度<1 cm,静脉直径≥8 mm。
- 建议避免对靠近皮肤的筋膜上大隐静脉行氰基丙烯酸酯闭合术,对直径≥8 mm的静脉应谨慎操作。
临床怎么用
- 术前评估静脉深度和直径,对高危静脉避免或谨慎使用氰基丙烯酸酯闭合术。
- 术后1周警惕超敏反应,轻症可用非甾体抗炎药和抗组胺药处理。
局限性
- 回顾性研究设计,样本量有限(101例患者126条静脉),结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The objective of this study was to evaluate the incidence of, the risk factors for, the nature of the disease, and the management of hypersensitivity reaction (HSR) after cyanoacrylate closure (CAC) of incompetent saphenous veins in patients with chronic venous disease. METHODS: Data consisting of all incompetent saphenous veins, including great saphenous veins, anterior accessory saphenous veins, and small saphenous veins, treated with CAC at Siriraj Hospital (Bangkok, Thailand) from January 2017 to December 2018 were retrospectively evaluated. RESULTS: A total of 126 saphenous veins, including 106 great saphenous veins (84.1%), 7 anterior accessory saphenous veins (5.6%), and 13 small saphenous veins (10.3%) of 126 limbs from 101 patients were included. A HSR occurred in 16 of 101 patients (15.8%), in 19 of 126 limbs (15.0%), and in 19 of 126 treated saphenous veins (15.0%). HSR-related erythema, itching, swelling, and pain occurred in 100.0%, 95.0%, 68.4%, and 52.6%, of HSR patients, respectively. HSR occurred 1 week after CAC. All HSR symptoms were mild, could be treated with nonsteroidal anti-inflammatory drugs (NSAIDs) and antihistamine, and were resolved within 1 week. The risk factors for HSR were suprafascial saphenous vein with a depth <1 cm from the skin, and saphenous vein diameter of ≥8 mm. CONCLUSIONS: A HSR occurred in 15.8% of patients and in 15.0% of limbs after CAC. Risk factors for HSR were a suprafascial saphenous vein located close to the skin and a large saphenous vein. All HSR symptoms were mild in severity, occurred at 1 week after CAC, and were resolved within 1 week after treatment with nonsteroidal anti-inflammatory drugs and antihistamines. To prevent HSR, CAC should be avoided in suprafascial saphenous veins that are located close to the skin, and CAC in saphenous veins with a size of ≥8 mm should be performed with caution.
引用
- Sermsathanasawadi N, Hanaroonsomboon P, Pruekprasert K, et al. Hypersensitivity reaction after cyanoacrylate closure of incompetent saphenous veins in patients with chronic venous disease: A retrospective study. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 33383235. doi:10.1016/j.jvsv.2020.12.074
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。